CN114875067B - Construction method of Bestrophin3 vascular smooth muscle specific gene knockout mice and aortic dissection mice models - Google Patents

Construction method of Bestrophin3 vascular smooth muscle specific gene knockout mice and aortic dissection mice models Download PDF

Info

Publication number
CN114875067B
CN114875067B CN202210598098.XA CN202210598098A CN114875067B CN 114875067 B CN114875067 B CN 114875067B CN 202210598098 A CN202210598098 A CN 202210598098A CN 114875067 B CN114875067 B CN 114875067B
Authority
CN
China
Prior art keywords
mice
best3
aortic dissection
flox
smko
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210598098.XA
Other languages
Chinese (zh)
Other versions
CN114875067A (en
Inventor
周家国
张亭亭
吕晓飞
梁思佳
雷青青
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Yat Sen University
Original Assignee
Sun Yat Sen University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Yat Sen University filed Critical Sun Yat Sen University
Priority to CN202210598098.XA priority Critical patent/CN114875067B/en
Publication of CN114875067A publication Critical patent/CN114875067A/en
Application granted granted Critical
Publication of CN114875067B publication Critical patent/CN114875067B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027New breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276Knockout animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The invention discloses a construction method of a Bestrophin3 vascular smooth muscle specific gene knockout mouse and an aortic dissection mouse model, and relates to the field of mouse model construction. The aortic dissection mouse model comprises the following construction steps: bestrophin3 vascular smooth muscle specific gene knockout mice, called Best3 for short SMKO Mice, rearing Best3 SMKO Aortic dissection or aortic aneurysm spontaneously formed in mice 24 weeks. The purpose of the application is that the Bestrophin3 deletion in vascular smooth muscle cells can induce aortic dissection, and the constructed Bestrophin3 smooth muscle specific knockout mouse is an aortic dissection/aneurysm mouse model with high morbidity and high quality similar to the incidence age of human aortic dissection, and Best3 SMKO The incidence rate of AD of mice reaches 63%, the incidence rate is high, and the modeling is simple.

Description

Construction method of Bestrophin3 vascular smooth muscle specific gene knockout mice and aortic dissection mice models
Technical Field
The invention relates to the field of mouse model establishment, in particular to a construction method of a Bestrophin3 vascular smooth muscle specific gene knockout mouse and an aortic dissection mouse model.
Background
Aortic dissection (Aortic Dissection, AD) is a common vascular acute disease, with the concomitant younger cardiovascular diseases such as hypertension, and the incidence of the disease increases year by year. The aortic dissection is extremely dangerous in disease development, and once the disease is developed, if the disease cannot be treated in time, the blood vessel is ruptured, so that the heart is tamponade, the trachea is caused to bleed acutely, and shock death is caused. Once the blood vessel of the aortic dissection patient is ruptured, the artificial blood vessel replacement can be carried out only through operation, the replacement faces huge operation risks, the blood vessel after operation can be further degenerated, and the risk of secondary operation and rupture is faced to prevent aortic rupture. At present, no medicine can treat and repair aortic dissection through repairing an aortic structure, and after a slight aortic dissection and critical aortic dissection operation, the occurrence and development of aortic dissection can be controlled only through maintaining blood pressure, blood fat and the like, so that the research on the pathogenesis of aortic dissection and the search of prevention and treatment targets become particularly important.
The animal model is a key tool for researching aortic dissection pathogenesis and drug research, and the current common aortic dissection mouse model is mainly constructed by the following 3 modes: (1) The apo lipoprotein E (ApolipoproteinE, apoE) knockout mice are added with angiotensin II to induce hypertension for 28 days, and the molding rate is about 40-60%; (2) Low density lipoprotein receptor (Low-Density Lipoprotein Receptor, LDLR) knockout mice plus angiotensin II induce hypertension for 28 days with a molding rate of about 40-50%; (3) Beta-aminopropionitrile was administered to 3 week old wild type C57LB mice for 4 weeks, followed by induction of hypertension with angiotensin II for 3 days with aortic dissection rates up to 90%. Although the above 3 methods are widely used, the method has certain defects that the (1) and (2) knockout mice have low molding rate, the pathogenesis is mainly in abdominal aorta, the pathological manifestation is more similar to that of abdominal aortic aneurysm, and the pathological manifestation of aortic dissection is different; the method (3) has high molding rate, but has strict limitation on the week age requirement of molding mice, and the mice with the age of 3 weeks are required to be used, which is inconsistent with the morbidity population of clinical aortic dissection, and has high death rate and large experimental loss during molding.
Therefore, development of a brand new mouse aortic dissection model which is simple in modeling method, consistent with human morbidity progress and characterization and high in modeling rate is urgently needed.
Disclosure of Invention
The invention provides a construction method of a Bestrophin3 vascular smooth muscle specific gene knockout mouse and an aortic dissection mouse model, and provides a brand-new mouse aortic dissection model which is simple in modeling method, consistent with human morbidity progress and high in morbidity.
In order to solve the technical problems, one of the purposes of the present invention is to provide a targeting vector of a Bestrophin3 vascular smooth muscle specific gene knockout mouse model, wherein the targeting gene comprises a Bestrophin3 gene and two Loxp sites, wherein the two Loxp sites comprise loxP inserted into an intron2 of the Bestrophin3 gene and FRT-Neo expression frame-FRT-loxP inserted into an intron4 of the Bestrophin3 gene.
Preferably, the sequence of the targeting vector is shown as SEQ ID NO. 1.
In order to solve the technical problems, the second object of the present invention is to provide a construction method of a bestophin 3 vascular smooth muscle specific gene knockout mouse, comprising the following steps:
(1) Adopting a Cre/LoxP recombination system, selecting exon 3 and exon4 of a Bestrobin 3 gene as knockout regions, deleting the regions to cause the loss of functions of the Bestrobin 3 gene of a mouse, using a C57BL/6 mouse genome as a template to amplify an upstream homology arm, a downstream homology arm and a flox region, inserting LoxP in an intron2 of the Bestrobin 3 gene, inserting FRT-Neo expression frame-FRT-LoxP in the intron4, and connecting the regions to a framework to form a targeting vector;
(2) The targeting vector is linearized and transfected into embryo stem cells of a C57BL/6 mouse, successfully homologous recombination embryo stem cells are identified and screened through PCR, and then the embryo stem cells with positive expression are microinjected into blastula and transplanted into pseudopregnant mice;
(3) Obtaining F1 generation hybrid mice through passage, and identifying the obtained Bestrophin3-flox heterozygote mice by utilizing PCR;
(4) Selfing and PCR screening the Bestrophin3-flox heterozygote mice to obtain Bestrophin3-flox homozygous mice, then hybridizing and breeding the Bestrophin3-flox homozygous mice with vascular smooth muscle Cre tool mice to obtain F1 generation hybrid mice, separating milk at 3 weeks and identifying the genotype of the F1 generation hybrid mice by using a rat tail method, hybridizing the Bestrophin3 chimeric flox heterozygote and Tagln-Cre positive mice with the Bestrophin3-flox homozygous mice again, and screening the Best3 homozygous and Tagln-Cre positive Best3 by PCR identification SMKO And (3) a mouse.
Preferably, the sequence of the targeting vector is shown as SEQ ID NO. 1.
Preferably, the Best3 SMKO Mice were initially aortic dissection modelling 4 weeks old.
As a preferred embodiment, the primers for identifying the Bestrophin3 vascular smooth muscle-specific knockout mice comprise:
Tagln-Cre-F:5’GCGGTCTGGCAGTAAAAACTATC 3’;
Tagln-Cre-R:5’GTGAAACAGCATTGCTGTCACTT 3’;
Best3_LoxP_F:5’GTGGCTGAGGCAGGAGAATTACA 3’;
Best3_LoxP_R:5’AACCTGTGGGAAAACCTCTATCTCC 3’;
Best3_Neo_Del_F:5’CAGAAGTAGCCGAAAGCCAAGATGCC 3’;
Best3_Neo_Del_R:5’TTACCTGGACGAAAACCGACAGCA 3’。
in order to solve the technical problems, the invention provides an application of a Bestrophin3 vascular smooth muscle specific gene knockout mouse in screening medicines for treating or preventing aortic dissection or aortic aneurysm.
In order to solve the above technical problems, a fourth object of the present invention is to provide a method for constructing an aortic dissection mouse model, comprising the following steps: best3 with Bestrophin3 Gene loss of function SMKO Mice, rearing Best3 SMKO Mice reached 8 weeks of age and beyond spontaneously developed aortic dissection or aortic aneurysm.
Preferably, the Best3 SMKO The sequence of the mouse targeting vector is shown as SEQ ID NO.1,
as a preferred embodiment, in Best3 SMKO The mice were kept at 4 weeks of age and induction of angiotensin II was performed for 28 days or more.
As a preferred embodiment, the induction concentration of angiotensin II is 1-2 mg.kg -1 ·d -1
Compared with the prior art, the embodiment of the invention has the following beneficial effects:
the purpose of the application is to confirm that the deletion of the Bestrophin3 in vascular smooth muscle cells can induce aortic dissection, and the constructed Bestrophin3 smooth muscle specific knockout mouse is an aortic dissection/aneurysm mouse model which has high morbidity and high quality and has similar morbidity and age with human aortic dissection, and the self-base of the mouse model can spontaneously form AD; if synchronous induction is carried out by adopting angiotensin II, the main body can be acceleratedArterial dissection or aneurysm formation, best3 SMKO The incidence rate of AD of mice reaches 63%, the incidence rate is high, and the modeling is simple.
Drawings
Fig. 1: the invention relates to a construction method of a Bestrophin3 vascular smooth muscle specific knockout mouse in the first embodiment;
fig. 2: schematic diagram of LoxP insertion site of bestophin 3 vascular smooth muscle specific knockout mice in the first embodiment of the present invention;
fig. 3: in the second embodiment of the present invention, the vascular smooth muscle-specific knockout mouse of Bestrophin3 (Best 3) SMKO ) And control mice (Best 3) FL/FL ) Survival curves within 72 weeks of age;
fig. 4: best3 in the second embodiment of the invention FL/FL Mice and accidental death Best3 SMKO Thoracic anatomy of mice;
fig. 5: best3 in the second embodiment of the invention FL/FL Mice and Best3 SMKO Ultrasound images of mice with respect to aortic arch and abdominal aorta (left) and statistics with respect to the inner diameters of ascending aorta (Ascending Aortic Diameter) and abdominal aorta (Abdominal Aortic Diameter) as a function of age of week (right);
fig. 6: best3 in the second embodiment of the invention FL/FL Mice and Best3 SMKO The vascular in vitro dissection results of the ascending aorta (Arch) and the abdominal aorta (Abao) of the mice at different ages;
fig. 7: best3 in the second embodiment of the invention SMKO Schematic representation of the pattern of aortic dissection development and progression in mice;
fig. 8: induction of Best3 by angiotensin II in embodiment three of the present invention SMKO Schematic flow chart of hypertension of mice;
fig. 9: in the third embodiment of the invention, the angiotensin II induces the Best3 within 4 weeks of hypertension FL/FL Mice and Best3 SMKO Counting survival curves in mice;
fig. 10: in-vivo ultrasonic detection of Best3 after 4 weeks of hypertension induced by angiotensin II in embodiment III of the present invention FL /FL And Best3 SMKO Aortic Arch of mouse (Arch)And abdominal aorta (AbAo) structural images and vessel inside diameter statistics;
fig. 11: post 3 after 4 weeks induction of angiotensin II in example III of the present invention FL/FL Mice and Best3 SMKO Isolated vascular anatomy of mice;
fig. 12: post 3 after 4 weeks induction of angiotensin II in example III of the present invention FL/FL Mice and Best3 SMKO Counting the incidence rate of aortic dissection of the mice;
Detailed Description
The following description of the embodiments of the present invention will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Bestrobin is a class of proteins having a molecular weight of about 68 kD. Up to now, the bestophin family has found 4 subtypes bestophin 1, bestophin 2, bestophin 3 and bestophin 4. The distribution of these 4 subtypes is tissue specific, with bestophin 1 being distributed predominantly in the basal membrane of retinal pigment epithelial cells, as well as in the lung epithelium and intestinal tract; the distribution of bestophin 2 is more limited to the olfactory epithelium and the eye; bestrophin4 is very rare in major tissues of the human body and is difficult to detect in many organs, while Bestrophin3 is widely distributed in tissues and its expression can be detected in many tissues.
As an important subtype of the Bestrophin family, bestrophin3 is currently known as 12 transcripts, 10 of which can encode proteins, and therefore, bestrophin3 exists in several spliceosomes, which exist in different forms in different tissues. In recent years, the study of Bestrophin3 has focused on structure and functionality. Wang X et al have shown that vitamin C is effective in inhibiting hydrocortisone-induced damage to microvascular endothelial cells, and is probably due to the promotion of Bestrophin3 expression; after neonatal brain injury in mice, bestophin 3 protein expression is up-regulated and co-expressed with Nestin. mRNA splice variants of Bestrophin3 differ in different damaged tissues, indicating that they function differently in damaged tissues; bestrophin3 can act on NF- κB to reduce inflammation induced by TNFα in endothelial cells by inhibiting its activation; meanwhile, the Bestrophin3 can inhibit the expression of CHOP, so that the cell death of kidney epithelial cells caused by endoplasmic reticulum stress is reduced; furthermore, researchers have found that Bestrobin 3 can also be used as a biomarker for breast cancer screening by proteomic analysis, wu et al have found that the C-terminal cleavage of mouse Bestrobin 3 can affect lysosomal-endosome complexes while promoting lysosomal swelling, calcium ion release in the endoplasmic reticulum, and the like. Demonstrating that bestophin 3 plays a role in regulating calcium ion release in myoblasts; in addition, golubinskaya et al found that Bestrophin3 has a higher molecular weight in podocytes and renal cortex than in the heart. The differences between predicted and observed protein weights in different tissues may be due to posttranslational modification of bestophin 3, but require further investigation to elucidate its underlying mechanism. While bestophin 3 is involved in a variety of physiological processes such as tumor, cell proliferation, inflammation, etc., its pathophysiological significance in cardiovascular system, especially vascular smooth muscle cells, is still unclear.
The application shows that the Bestrophin3 deletion in vascular smooth muscle cells can induce aortic dissection, and the Bestrophin3 smooth muscle specific knockout mouse is a high-quality aortic dissection/aneurysm mouse model with high morbidity and similar morbidity and age of human aortic dissection.
Example 1
The construction method of the Bestrobin 3-fLoxP mouse model specifically comprises the following steps:
(1) Materials: construction of Bestrobin 3-flox mice (C57 BL/6 mice) entrusted with Sai-Boc Biotech Co., ltd; B6.Cg-Tg (Tagln-cre) 1Her/J mice used for the experiments were derived from The Jackson Laboratory; c57BL/6 mice were derived from Siro Biotech Co; PCR identification kits were purchased from sigma company, USA; .
(2) Construction of plasmid vector:
as shown in FIG. 1, a Cre/LoxP recombination system is adopted to construct a conditional knockout mouse, a Bestrobin 3 conditional knockout vector is firstly constructed, the Bestrobin 3 gene has 10 exons, ATG is on exon 2, TAA is on exon10, exon 3 and exon4 of the Bestrobin 3 gene are selected as knockout regions, and deletion of the regions should lead to the loss of function of the Bestrobin 3 gene of the mouse. The C57BL/6 mouse genome is used as a template to amplify an upstream homology arm, a downstream homology arm and a flox region, loxP is inserted into an intron2 of a Bestrophin3 gene, FRT-Neo expression frame-FRT-loxP is inserted into an intron4 and is connected to a framework, a LoxP insertion site is schematically shown in FIG. 2, a targeting vector (with Neo marker genes) is formed, and the nucleotide sequence of the targeting vector is shown as SEQ ID NO: 1.
(2) The targeting vector is linearized and transfected into embryo stem cells of a C57BL/6 mouse, successfully homologous recombination embryo stem cells are identified and selected through PCR, primer sequences used for PCR are shown in table 1, and then positive embryo stem cells are microinjected into blastula and transplanted into a pseudopregnant mouse.
(3) F1 generation mice were obtained by passaging, and the obtained Bestrophin3-flox heterozygote mice were identified by PCR using the primer sequences shown in Table 1.
(4) Reproduction and screening of bestophin 3 vascular smooth muscle specific knockout mice:
the Bestrobin 3-flox heterozygous mice are subjected to selfing propagation and PCR screening to obtain the Bestrobin 3-flox homozygous mice, and then the Bestrobin 3-flox homozygous mice are subjected to hybridization propagation with vascular smooth muscle Cre tool mice, namely B6.Cg-Tg (Tagln-Cre) 1Her/J mice, which are abbreviated as Tagln-Cre mice. The F1-generation hybrid mice obtained were weaned at 3 weeks and their genotypes were identified by the rat tail method, and Bestrophin3 chimeric flox heterozygous and Tagln-Cre positive mice were again crossed with Bestrophin3-flox homozygous mice.
(5) The mice obtained were identified by PCR, the primer sequences used for PCR are shown in Table 1, and a control group (Bestrophin 3-flox homozygote and Tagln-Cre negative, i.e., best 3) was obtained by screening FL/FL Mice) and experimental groups (Bestraphin 3-flox homozygous and Tagln-Cre positive, i.e., best 3) SMKO Mice) that were allowed to aortic clamp at 4 weeks of ageAnd (5) layer molding.
TABLE 1 primer sequences for PCR identification in example one
Figure BDA0003668903660000071
Figure BDA0003668903660000081
Example two
Verification Best3 SMKO AD spontaneously forms in the basal state of mice: to clarify the role of Bestrophin3 in AD formation, a Cre/LoxP conditional gene targeting technique was used to construct and obtain a Bestrophin3 vascular smooth muscle specific gene knockout mouse (Best 3) SMKO ) Using Best3 flox+/+ As a control group (Best 3) FL/FL )。
The test steps are as follows: recording Best3 under natural growth state SMKO And Best3 FL/FL Drawing a survival curve according to death conditions of mice within 4-72 weeks of age; the internal diameter of the aorta is detected by adopting the ultrasonic Doppler of a living animal, and the blood vessel of the mouse is peeled off by using an anatomical means to further define the structural change of the blood vessel of the mouse, so as to jointly evaluate the influence of the smooth muscle knockout of Bestrophin3 on aortic dissection/aortic aneurysm of the mouse.
Test results: as shown in FIG. 3, best3 increased with age during raising of mice SMKO Mice show slow movement and unexpected death, and the death conditions of the mice with different ages are recorded and counted, so that the Best3 knockout can cause the survival time of the mice to be shortened and the death rate to be obviously increased. Best3 with unexpected death SMKO The mice were dissected in the presence of a standing horse, as shown in fig. 4, and severe hematocele was found in the chest, and the dissected aorta was seen to form a clear aortic dissection and to appear as an abdominal aortic rupture. As shown in fig. 5, the abdominal aorta (AbAo) and the ascending aorta (Arch) were observed and the vessel inner diameter was measured by performing in vivo ultrasound monitoring of the aortic structures in two groups of 4-week, 8-week, 12-week, 16-week, 20-week, 24-week, 48-week, 72-Zhou Zhouling mice, respectively; as shown in fig. 6-7, and performs an anatomic viewAnd (5) inspecting. As a result, after the Bestrobin 3 is knocked out, the aorta of the mice forms aortic blood clamping at an early stage, namely, the aortic dissection is early-stage and is light, the vessel wall hematoma occurs, the inner diameter of the vessel is obviously increased along with the age, and the vessel wall structure is further destroyed to form the dissection aneurysm.
Example III
Angiotensin II (Ang II) induced Best3 SMKO Test of hypertension and aortic dissection in mice:
the elevation of blood pressure is an important cause of occurrence and development of aortic dissection, and is characterized in that an Ang II slow-release pump is buried subcutaneously on the back of a 4-week-old mouse to induce hypertension for 4 weeks in order to simulate the pathological condition of hypertension during clinical aortic dissection, and the induction flow is shown in figure 8, and comprises the following steps:
(1) To Best3 FL/FL Mice and Best3 SMKO At 4 weeks of age, two groups of mice in the same litter were anesthetized by intraperitoneal injection of pentobarbital sodium (100 mg/kg) BW ) Micro-osmotic slow release pump with Ang II solution (1.75 mg/kg) was subcutaneously implanted in the back, the rate of releasing Ang II was 1.44mg/kg/d, and the systolic pressure (Systolic blood Pressure, SBP) and diastolic pressure (Diastolic blood Pressure, DBP) of the mice were tracked and examined with a noninvasive sphygmomanometer 7 days, 14 days, 21 days, 28 days after the implantation of the pump, respectively, and the survival curve of the statistical mice was shown in FIG. 9, and the survival rate after 28 days was 78%.
(2) The ultrasonic detection of mice is carried out by using a VEVO 3100 ultrasonic device (Visual sonic Canada Toronto), firstly placing the mice to be detected in an anesthesia box, carrying out anesthesia to coma by using 2% isoflurane, then fixing the mice to be detected on a carrier plate, continuously carrying out anesthesia by using 1% isoflurane, respectively collecting images of an ascending aorta, an aortic arch, a thoracic aorta and an abdominal aorta by selecting proper positions, observing the structure of the whole aorta and whether an aortic aneurysm is formed or not, and simultaneously measuring the maximum inner diameter of the whole aorta, wherein the image result is shown in figure 10. The sample was simultaneously dissected and the results are shown in fig. 11.
Test results: as shown in FIG. 10, at day 28 after induction of hypertension, the wall structure of the aorta of the mice was observed by scanning with ultrasound, and Best3 was seen SMKO The aorta of the mice risesAortic and abdominal aortic and the like form arterial distension and generate a dissection aneurysm, best3 SMKO The diameter of the aorta of the mice is obviously increased. Further anatomical observations were made, as shown in FIG. 11, the anatomical map can be seen in Best3 SMKO Aortic dissection occurs in the abdominal aorta and forms a tumor-like enlargement. As shown in FIG. 12, best3 SMKO The AD incidence rate of the mice is 63% and is far higher than that of Best3 FL/FL A group.
The foregoing embodiments have been provided for the purpose of illustrating the general principles of the present invention, and are not to be construed as limiting the scope of the invention. It should be noted that any modifications, equivalent substitutions, improvements, etc. made by those skilled in the art without departing from the spirit and principles of the present invention are intended to be included in the scope of the present invention.
Sequence listing
<110> university of Zhongshan
<120> construction method of Bestrophin3 vascular smooth muscle specific gene knockout mice and aortic dissection mouse models
<160> 7
<170> SIPOSequenceListing 1.0
<210> 1
<211> 15721
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<220>
<223> targeting vector
<400> 1
ctaaattgta agcgttaata ttttgttaaa attcgcgtta aatttttgtt aaatcagctc 60
attttttaac caataggccg aaatcggcaa aatcccttat aaatcaaaag aatagaccga 120
gatagggttg agtgttgttc cagtttggaa caagagtcca ctattaaaga acgtggactc 180
caacgtcaaa gggcgaaaaa ccgtctatca gggcgatggc ccactacgtg aaccatcacc 240
ctaatcaagt tttttggggt cgaggtgccg taaagcacta aatcggaacc ctaaagggag 300
cccccgattt agagcttgac ggggaaagcc ggcgaacgtg gcgagaaagg aagggaagaa 360
agcgaaagga gcgggcgcta gggcgctggc aagtgtagcg gtcacgctgc gcgtaaccac 420
cacacccgcc gcgcttaatg cgccgctaca gggcgcgtcc cattcgccat tcaggctgcg 480
caactgttgg gaagggcgat cggtgcgggc ctcttcgcta ttacgccagc tggcgaaagg 540
gggatgtgct gcaaggcgat taagttgggt aacgccaggg ttttcccagt cacgacgttg 600
taaaacgacg gccagtgaat tgtaatacga ctcactatag ggcgaattgg gtacgcggcc 660
gcaccctgga ctcactacac gctggatcgc cacagcagca ggagaactag gaggaaaccc 720
agctggtcac cagtgagggt ggaagccggc acctcttcag ggacggcaga tcgtttgaag 780
atttctcttc ccttgagaga ctccaaagaa ataggttagt gcgcgagccg gcttctgcac 840
ttgaacgtga ccttatgctt ggtgggcgtc gggtttcgga cagagcctga actgagggtg 900
aaggagtgaa tggaagaaaa ggggattggt tagaggctgt cccttgacgg ggcctgcctg 960
gagaagagct taggacattg ctgttctgtt ctcccctgtc gctgagttct cccgaggcag 1020
agagacaagg tggcgatctc aaagcgaagc ctgttttagg gcaggcaccc cacccttctg 1080
tggtgtcacc tactgactta ggcaaagggc cctggtttgt ttaattaaaa tcaacaacca 1140
tggaggacaa atcagcactt tgctgttgtt gctgtggata cagctgccag ctcttacgtc 1200
cttagagaaa ctggataaat cacagttgga tatttgcctg tctaaatgaa acattctctt 1260
atttgtgata gaatgtgtga tataaatcgc tctacggggg gaaaaaaata tgctctaggg 1320
tttgtttggt tgggtttttg tgtgggtgtg tgtattataa ttttgaccta aaatctatca 1380
gcctgtgttg ctctgtgaga agttctttgt agttcctttg gagaaaagtt aacattttaa 1440
agagatctcc ttttgtttgc atgtgaccta tactacccag ttagctgagt aaggtttcca 1500
aacaaaggtc ggctttgagc catctattcg aagtccgatg gcacatctca gtgagaagcc 1560
gaggcatgcc agggagctca aagaaaactg ggattaggcc ccattctcat cctgcccacg 1620
tccacgaaat gaatccagaa caaggtgttc taaattacag acacactagg gatgtagcac 1680
acatgagaca gtgcctgccc agcacacaca agactcggtg ccaagcaaaa cgctaagtaa 1740
atactacata cagtggcggt ggtacagtcc cacaattcca gcgctcactg gaaatggagc 1800
aaaagttcaa ggccaggttc aaggtcaatg tgggatgacc ctgtcttcca aaataagaaa 1860
gaaaagactc agtttgtttg tctctgatta tttcattgag actttccaag gggaaagtgt 1920
agccttttta atatcaagtt tacggctccc tttgaaaggt acagaattcc gactgtacac 1980
cctgagagct gctgagagac tcacatctca ggaagatacc cccacccccc gacacaccca 2040
agtagcccat ctgttaaact gctctggggg ccgggcttcc tcctgacaat cgctcctggt 2100
tcctaagaag ggatcaataa ctttttcctc ttaggaagtt taaaggtgaa atcaatattt 2160
ctttaaggat tttagcagac actggcccaa acaacgagta tagccactgc tttttaaaaa 2220
catcatcagt ttagcaaacc aatttcctaa atcctcctgc gactaagaag tggctagtat 2280
gcctcatgtg ctaatgttga ttatgtattg ggcaaaagct acagactcta aaataatgct 2340
tatcgaatgc agaaatgtca gggcttctaa aaacagtctt tctagggacc atcttcttct 2400
ccttctgtgt cagatttagt gccgagatgc tagatggtga tacggtatta tctacaagtt 2460
ctaaactatg agaggagtgc gtgatgcatg gagggtgggt cagctgatta gtttttggct 2520
ttagtttcct ttggttaaga aagaaaggga aagtgtatgc ctgtgttgac atccaacttt 2580
gcttttcact cgtgttttgt cttcttgctc ttctagaaca aaaccaccca cgatgactgt 2640
cacttactcc agtaaagtag caaatgcaac attttttgga tttcataggt tgcttctcaa 2700
gtggagaggt agtatctaca agctgctgta cagggaattt attgtttttg ctgttcttta 2760
cacagcaatc agtctggtgt acaggtacct tcgttttgca tgtctcctta aatggccccc 2820
ccaggcatta tgtaagaata cagtctcaaa aactggatcc ccttggttgc cgctagcctc 2880
tgcattatgt aacaatctcc ccacccctcc ccaccccccg catgaacctc tctggcgtcc 2940
tctcttcagg atagggtatt ttaatccaca cctaaccacg tatttggagc aattgacagc 3000
caccgttcag acaatgggct ctaattccag ccccacagag atggatcccg atgaggtatc 3060
agcctagctg ctttaagtgt caactgaaag ttttatgctg acatcctcat cggtgtgccg 3120
attaacggcc aaagcccaca gacaaatgct tttgtgtttc tctcagtgat gtcatgtgga 3180
gtttgaacat gtgatctgac agcttactgc aactctacgt ggagttaaca tatgggtgaa 3240
tagaatttac cagacagctt tccttcctgt agtctggatg gtaagctctg acctgggatg 3300
atgtcctcca acctcaccaa agaactaagg cctgaggaat aatttgttct ctttatgtct 3360
tctgatttca ggatgtcaca tttgcaagag aaggtatcta ttctttataa cacgggtacc 3420
tgtcaggttc atactttgag ggctagcata tccacctctc ccaactgaaa agtattgtct 3480
tagtaacatt tcatcactgt gattaaaaaa aaatgaagct ttaggagtta ataaactaaa 3540
actgaattac attggaggaa gctaaaagga aagcctaaga ttttcaaggc tgtatttcca 3600
ccttagctag gtataaaatt ttttcttcca tcgaaggtga actaactgtg agtcacagtc 3660
tcacctacat ccttctttga aactatgaga ctccacttgg agaggagagg tattcattta 3720
gttggctgat catttccaaa agcaaactgt gaacaactat cttgttcaca acaacccatc 3780
agtacttcca gcccaaagat gaggatgtag ctcagttggt acaatgcctg cctagcaagc 3840
acaaaaccct gaactcaatc cccaggcact gatagcacac acctgtaatc ccagtattga 3900
ggcaatggag acaggaggat cctgttcaag ataacttgct gcttgagtta taagaaactc 3960
tgtcaaaaaa aaaaaagaca gaacactatc attccatacc agtatacata ttagaacaga 4020
ttttgtggga ctaaggaatt agctcagtgg tagaatgctt tgcctagcaa ctggcaggct 4080
ctgggttcag tccccagttc aaaaataatc agaacaaaaa acaccaaggc aaaaatcgca 4140
agaatagatt tttgtcaaat attcttagag acgtctgata tctttcagat atctcctata 4200
ttaccttaac agttcactta tctgttcctt gaaccttcag agtatgacat ggtggcagat 4260
tagtggtgtt ccagtatcac tatctcatca gttcattctt cactaatgtg agtttactgc 4320
tgctactgct gtttagaaga gagaagcccc aagagcaact gctatatccc tggaaatgct 4380
ccaatatcaa acttacaccc caaaactcta cacagatttt tgtctttcca aagatcaaag 4440
agtacaaaca ttcgcagcaa tcactttaac ttgctttttt cttctttttt aaaaaagtct 4500
cattgtaaat tcttataaaa gcagatcctt tttatcttaa atatttacca agaactgttg 4560
gattcatagg tctccaaaat caagcagacc tgaaaatata accatagttt gtgctttgcc 4620
tggtattgac tttgagttta actcttccag tttggaggaa tttgacataa tactctctgt 4680
ggtattttct agataagaat atccacatat atctgtccaa ttagcatcaa taccacccat 4740
tttggtgcta cgtttgaaga tatacagttg ccttacagtt atttatgtaa ttgatatttc 4800
tggtctttac aacaccataa actaaaaaga accctgagac tcctagagct ttgacaatat 4860
ccccaagtct aaatctatga caaacctgtt ctataccttg gcctggccca gctgatccca 4920
ggagctgtgc tttctacact gaatacttta atgtgcataa ttaaatactt tatgtatcag 4980
aaagccgctc tgtgacttgt tatcaacagg accctccctg attccacgaa cttgatcgcc 5040
tcacccaaag ctgacacaag aactccccac aacccctata cctcaaattc tttattcacc 5100
aagaccagcc tgacagtcct ctgcctgcag cccccgtggc tggacactgc tcctcttcta 5160
tcagcattcc actcacgggc gggaactttt gagacttgtt ccgataggtt ttttcttaga 5220
tttcttgttc tttagatgaa ctgaactatt aatctatgca aattcatatg tagcctctct 5280
ttccacatcc tggtaattat tattaatgtg tctttagatt ccttctggct ctgaattccc 5340
tccctgaaac ataataacgg tctcattatg ggcaggtgtg tttagcaatc tcagaaaata 5400
agtttgggga ggtaaagtca gatctacagg aaaggttttg atatttgagc ccatggccaa 5460
atataacagt gaaagtttct gcctttcagg ttaaatcagc tttatttata tcccaagcat 5520
tgcgaatatt aaagtaaaca atcacaatat ttcctgacag gtagtatatg cacaatctag 5580
aatgcattaa ttggcttggt taaattagta cgttctggat taaaggtcaa gatgttgaat 5640
gttactcaat aatgacttaa taactcttac ccaccaaatc aatagtctct ttcttttaag 5700
tattcctaat gaataattga aaaatggaaa ccaagcctgg tggtgaaggc ctataacctc 5760
agctaattga gtggctgagg caggagaatt acaaggacag gtaggtcgtc gcacgtataa 5820
cttcgtataa tgtatgctat acgaagttat tactgcgtac gagcatcgat ttcagggtct 5880
gcttggtcaa cagcagcagt tctcaacctt cctgatgctg tagtccttta atacagtccc 5940
tcatgttgtg gtgaccccca ccccccaccc cgaaccataa cactattctg ctttctactt 6000
cacaactgta atcttgctac tgttatgaat tgtaatttaa atatttttgg agatagaggt 6060
tttcccacag gttgagaacc actagtctat aacatgagct caagccaatg gggcgacccc 6120
tgtctcaaaa cagaaaagag tgacctgccg gtggtattca gtgattgtct gtctgacacg 6180
ccccggccct ggctttaatt ctcagaaaga aaaacaaaag actcttttgt aacatgtctt 6240
tctccaaaat ccaatgaacc agttatataa aactttaaaa ctacaaagct ttaagaaacg 6300
aagtggttaa caattccatt acttaatggt tatcagattt atgtgctaaa aacctttaat 6360
accggaagca caaagcattt ttttttttta aattttagag gcacaccagt tcaagggaaa 6420
acaaaaaaca aaaacaaaac aaaaaacaac aacaacaaca acaacaaaaa accaagccaa 6480
ctgagattaa gatttgtggt taactgtttg cacttgctgt ctcctgcaga gcaggggcag 6540
gagttccgcg tcataaaggg ctgtgcgttt tatttttgct ccagattgtt acttacagga 6600
gcccaaaaac gttactttga aaaattatca atttactgtg acagatatgc tgaacaaatt 6660
ccagtaacct ttgtgcttgg taagtatagg tcacacgcag aatgcagcca cacagctgtc 6720
tccgttagat gacacagatg accgcatgag agtgcttccg ggctgtgagg cttgccggga 6780
aagccgctgc ttgcaatcgt gcacagccga ccctaaagtt cgccttcagg gctgcttctg 6840
ctaagttagc atgggacagt ttgaggtcgt aatctgctgt tggaccttta agctttctct 6900
tcactaaccg tccatttttg cagtcagtat ttgagttcta atacccactt accgggtgcc 6960
ctgaccttgt caggcatata tggcatttcc tcccctccag gagggcagaa atcctaaggt 7020
ctggaggata acatattttc atagctcgaa cccctaagaa agctaaaatt ctgctacacg 7080
tgtgtccgct gagatgtctg ctgtaagaaa ctgcatgatg gcgtctggtt atcccaacag 7140
ggttttacgt cactctggta gtgaaccgat ggtggaacca gtttgtgaat ctgccttggc 7200
cagacaggct gatgctcctc atttccagca gtgtccacgg gagcgaccag catgggcgcc 7260
tgctcagaag gacgctgatg cgctacgtca acctgacgtc cctgctcatc ttccgctcgg 7320
tgagcaccgc ggtgtacaag aggtttccca ccatggacca cgtggtcgaa gcaggtacgg 7380
ggtgtgcgct tggtaggagc caccaaaatg cttttgaaag cacccgggtg tatttattca 7440
agaaatgtgg cagaagcatt cttaaagggc aaagataagt aggtaagata ggactcctgc 7500
cctcaagaag tttccttggc aggtagaaga cagaagtagc cgaaagccaa gatgccttaa 7560
gataaataat acagtgatgg tgatcggtca ttaaaagcaa tttattttgt ttattttgtt 7620
ctgtttttca cttgtttttt gctttgttgg tggtgtttgt ttgtttgttt gttttacttg 7680
gtttggcttt ggctttggat atcgaattcc gaagttccta ttctctagaa agtataggaa 7740
cttcaggtct gaagaggagt ttacgtccag ccaagctagc ttggctgcag gtcgtcgaaa 7800
ttctaccggg taggggaggc gcttttccca aggcagtctg gagcatgcgc tttagcagcc 7860
ccgctgggca cttggcgcta cacaagtggc ctctggcctc gcacacattc cacatccacc 7920
ggtaggcgcc aaccggctcc gttctttggt ggccccttcg cgccaccttc tactcctccc 7980
ctagtcagga agttcccccc cgccccgcag ctcgcgtcgt gcaggacgtg acaaatggaa 8040
gtagcacgtc tcactagtct cgtgcagatg gacagcaccg ctgagcaatg gaagcgggta 8100
ggcctttggg gcagcggcca atagcagctt tgctccttcg ctttctgggc tcagaggctg 8160
ggaaggggtg ggtccggggg cgggctcagg ggcgggctca ggggcggggc gggcgcccga 8220
aggtcctccg gaggcccggc attctgcacg cttcaaaagc gcacgtctgc cgcgctgttc 8280
tcctcttcct catctccggg cctttcgacc tgcagcctgt tgacaattaa tcatcggcat 8340
agtatatcgg catagtataa tacgacaagg tgaggaacta aaccatggga tcggccattg 8400
aacaagatgg attgcacgca ggttctccgg ccgcttgggt ggagaggcta ttcggctatg 8460
actgggcaca acagacaatc ggctgctctg atgccgccgt gttccggctg tcagcgcagg 8520
ggcgcccggt tctttttgtc aagaccgacc tgtccggtgc cctgaatgaa ctgcaggacg 8580
aggcagcgcg gctatcgtgg ctggccacga cgggcgttcc ttgcgcagct gtgctcgacg 8640
ttgtcactga agcgggaagg gactggctgc tattgggcga agtgccgggg caggatctcc 8700
tgtcatctca ccttgctcct gccgagaaag tatccatcat ggctgatgca atgcggcggc 8760
tgcatacgct tgatccggct acctgcccat tcgaccacca agcgaaacat cgcatcgagc 8820
gagcacgtac tcggatggaa gccggtcttg tcgatcagga tgatctggac gaagagcatc 8880
aggggctcgc gccagccgaa ctgttcgcca ggctcaaggc gcgcatgccc gacggcgatg 8940
atctcgtcgt gacccatggc gatgcctgct tgccgaatat catggtggaa aatggccgct 9000
tttctggatt catcgactgt ggccggctgg gtgtggcgga ccgctatcag gacatagcgt 9060
tggctacccg tgatattgct gaagagcttg gcggcgaatg ggctgaccgc ttcctcgtgc 9120
tttacggtat cgccgctccc gattcgcagc gcatcgcctt ctatcgcctt cttgacgagt 9180
tcttctgagg ggatcaattc tctagagctc gctgatcagc ctcgactgtg ccttctagtt 9240
gccagccatc tgttgtttgc ccctcccccg tgccttcctt gaccctggaa ggtgccactc 9300
ccactgtcct ttcctaataa aatgaggaaa ttgcatcgca ttgtctgagt aggtgtcatt 9360
ctattctggg gggtggggtg gggcaggaca gcaaggggga ggattgggaa gacaatagca 9420
ggcatgctgg ggatgcggtg ggctctatgg cttctgaggc ggaaagaacc agctggggct 9480
cgactagagc ttgcggaacc cttcgaagtt cctattctct agaaagtata ggaacttcat 9540
cagtcaggta cataatataa cttcgtataa tgtatgctat acgaagttat taggtggatc 9600
cactaggcgc gccgatatcc tttggctttg gttttggttt gtgagacagg ttatcactgt 9660
gtagcccagg ctggccttga actcactgca atcctcctgc cttagcctcc ctggtggtgg 9720
gattacagat gtgagccacc gagcctagtt tatagctatt ccagttaggt ctcaggatgt 9780
cctgaaaaca gtagaaggtg gattttagag attgcaagcc gtcctgagtc acatagctgc 9840
agagcggaag gaagagaatt aatattcagg ctcagaaacg ctataataaa atgtgtcttg 9900
aagcaaagtt gaaggctggt ttgctgtcgg ttttcgtcca ggtaaattgg gtgaaaccct 9960
cctccccgga tgtggtagtg aaaggctctc tcagggtgga cctgttgtct ctcttgtgtt 10020
tcatgagacg gtagatgtag ctattctatg taggttcctg ggtcgttcct gggcctagca 10080
tgctgaaaac gagtcacgtg tgaggtatgg tgctctctgg tatgtaaatg tttagtgaag 10140
aagctgttca gccagcaagg gcggagtgag gtcattcctg gcccacagtg atgatccggg 10200
tgctcgattc tgccttcatt taggctgcaa agtaagaaaa cgaaagtgta ctctccagtg 10260
tccattttcc tccaagaaga aaactggagg gttttgtttg tttgggtttg tttttgtttt 10320
tactttgatg tctttctcct tgttttgagg tttttttatt ttatgttttt attatttttt 10380
tatttgatgg gtagcacaga taatatctaa gagcacatag cacaagggtt ggaattctga 10440
ctccaccgct cactagtcac atgacagtgc ttaggtactt agccttcctg tgcctctatc 10500
ttcacatcta taaaatgggc ttatgctagc gcaaataggt tgtacatctt gtaggttcag 10560
tgtgagaact aagtaagttg atattcctag cacctggaaa ggactgtgta ctttcttgct 10620
acattaaagg agccatccag accggctagt acaagatttt ggtcacttct gaggaatcct 10680
cgtgcccatg acagcccaga tattccagat ctattttcac cacaagattc agaaagtcgg 10740
ggcagggaaa gaaagcaagg gtatatgtac gtgataggcc atttctccac cagtgaaatg 10800
agccgattca aggcagatta gagtatatta cggcaggttt gttgggaagt tgctctaagg 10860
aaagttcact ggccccctag actgagatca aggaagttac catggagagg gggtggggga 10920
gagaaagaga gaaagggtgt gtacagggag agaagacaga gagagagaga aggggggaga 10980
gagagggggc gtggaaaatg cctggattat atcatgaaga acctctaaag gaagggcagc 11040
ccagccccta ggctggaaag ttcagaactg ggggcagggt ttgtcaggta gggactgagg 11100
gatgctggga gaatctggag gccagatctg atttgatatg taaactatgc acctcagttc 11160
cttgtccctg ggtcctaaat caaaccgtaa gaaagttgtg gggtgcaagg aactagtgga 11220
ggatccaggc agaaggttga gtagcctggc aaacacacag gggtattgtg tgaaatgcca 11280
ggatccaaaa ccgaagtaac cgcctgctgt ccccccagtg tatatgtagg ataacttcag 11340
aataactagc ctgaaccgct cctgggcagc ttcagtttct taccctacca ctgactgacc 11400
tcttgtgcat ctaaagtgca ttgccctggg ccccactttg aacttactga ccataaccaa 11460
cttgaacctt tagatgtcat gcttagaccc ctcagttaga cacgctgcca tgtctctccc 11520
tctgtctctg tattttaaga caatcttgtc acctagccca gacttgtctc tcatgggatc 11580
aaaaatgtac atcctcattc ttgactccat gtcactttcc tgcacagagg ttgacaagca 11640
cttagtcttt aaggggacgc ttcaaaagca aacaacaaca gaactctttc tgattcctgg 11700
caaaaaagga agagggagag gataagagcc atcaccacta acaaataccc acaaagaaga 11760
cgtagattta gaccatagcc ttcctgggga ctgaggaatt ctagggcatg ccctcgggca 11820
gtgagtctga gtaacttgtt tatacatagc tagcatagtt cttggtttaa aagtcttagt 11880
ttcttaggac tggatgaagg agacaaaaaa aaacaaaaaa caaaaaaaac aaaaaaaaaa 11940
aaaaaacaag agattagatg gagccaaatc tttcttagag ctcatgaacc tgtgactcat 12000
accaaccata aaagggcccc attgatcctg ggacaatggc agatagtggg ggctcctagg 12060
atcgcccggg ttgattcgag gctgctaaca aatcgagcag tgtggttttc aagaggaagc 12120
aaaaagcctc tccacccagg cctggaatgt ttccacccaa tgtcgagcag tgtggttttg 12180
caagaggaag caaaaagcct ctccacccag gcctggaatg tttccaccca atgtcgagca 12240
aaccccgccc agcgtcttgt cattggcgaa ttcgaacacg cagatgcagt cggggcggcg 12300
cggtcccagg tccacttcgc atattaaggt gacgcgtgtg gcctcgaaca ccgagcgacc 12360
ctgcagcgac ccgcttaaca gcgtcaacag cgtgccgcag atcttggtgg cgtgaaactc 12420
ccgcacctct tcggccagcg ccttgtagaa gcgcgtgcca tggatcctga tgatgttgtt 12480
gattcttcta aatcttttgt gatggaaaac ttttcttcgt accacgggac taaacctggt 12540
tatgtagatt ccattcaaaa aggtatacaa aagccaaaat ctggtacaca aggaaattat 12600
gacgatgatt ggaaagggtt ttatagtacc gacaataaat acgacgctgc gggatactct 12660
gtagataatg aaaacccgct ctctggaaaa gctggaggcg tggtcaaagt gacgtatcca 12720
ggactgacga aggttctcgc actaaaagtg gataatgccg aaactattaa gaaagagtta 12780
ggtttaagtc tcactgaacc gttgatggag caagtcggaa cggaagagtt tatcaaaagg 12840
ttcggtgatg gtgcttcgcg tgtagtgctc agccttccct tcgctgaggg gagttctagc 12900
gttgaatata ttaataactg ggaacaggcg aaagcgttaa gcgtagaact tgagattaat 12960
tttgaaaccc gtggaaaacg tggccaagat gcgatgtatg agtatatggc tcaagcctgt 13020
gcaggaaatc gtgtcaggcg atctctttgt gaaggaacct tacttctgtg gtgtgacata 13080
attggacaaa ctacctacag agatttaaag ctctaaggta aatataaaat ttttaagtgt 13140
ataatgtgtt aaactactga ttctaattgt ttgtgtattt tagattccaa cctatggaac 13200
tgatgaatgg gagcagtggt ggaatgcaga tcctagagct cgctgatcag cctcgactgt 13260
gccttctagt tgccagccat ctgttgtttg cccctccccc gtgccttcct tgaccctgga 13320
aggtgccact cccactgtcc tttcctaata aaatgaggaa attgcatcgc attgtctgag 13380
taggtgtcat tctattctgg ggggtggggt ggggcaggac agcaaggggg aggattggga 13440
agacaatagc aggcatgctg gggatgcggt gggctctatg gcttctgagg cggaaagaac 13500
cagcccgggc ggtggagctc cagcttttgt tccctttagt gagggttaat ttcgagcttg 13560
gcgtaatcat ggtcatagct gtttcctgtg tgaaattgtt atccgctcac aattccacac 13620
aacatacgag ccggaagcat aaagtgtaaa gcctggggtg cctaatgagt gagctaactc 13680
acattaattg cgttgcgctc actgcccgct ttccagtcgg gaaacctgtc gtgccagctg 13740
cattaatgaa tcggccaacg cgcggggaga ggcggtttgc gtattgggcg ctcttccgct 13800
tcctcgctca ctgactcgct gcgctcggtc gttcggctgc ggcgagcggt atcagctcac 13860
tcaaaggcgg taatacggtt atccacagaa tcaggggata acgcaggaaa gaacatgtga 13920
gcaaaaggcc agcaaaaggc caggaaccgt aaaaaggccg cgttgctggc gtttttccat 13980
aggctccgcc cccctgacga gcatcacaaa aatcgacgct caagtcagag gtggcgaaac 14040
ccgacaggac tataaagata ccaggcgttt ccccctggaa gctccctcgt gcgctctcct 14100
gttccgaccc tgccgcttac cggatacctg tccgcctttc tcccttcggg aagcgtggcg 14160
ctttctcata gctcacgctg taggtatctc agttcggtgt aggtcgttcg ctccaagctg 14220
ggctgtgtgc acgaaccccc cgttcagccc gaccgctgcg ccttatccgg taactatcgt 14280
cttgagtcca acccggtaag acacgactta tcgccactgg cagcagccac tggtaacagg 14340
attagcagag cgaggtatgt aggcggtgct acagagttct tgaagtggtg gcctaactac 14400
ggctacacta gaagaacagt atttggtatc tgcgctctgc tgaagccagt taccttcgga 14460
aaaagagttg gtagctcttg atccggcaaa caaaccaccg ctggtagcgg tggttttttt 14520
gtttgcaagc agcagattac gcgcagaaaa aaaggatctc aagaagatcc tttgatcttt 14580
tctacggggt ctgacgctca gtggaacgaa aactcacgtt aagggatttt ggtcatgaga 14640
ttatcaaaaa ggatcttcac ctagatcctt ttaaattaaa aatgaagttt taaatcaatc 14700
taaagtatat atgagtaaac ttggtctgac agttaccaat gcttaatcag tgaggcacct 14760
atctcagcga tctgtctatt tcgttcatcc atagttgcct gactccccgt cgtgtagata 14820
actacgatac gggagggctt accatctggc cccagtgctg caatgatacc gcgagaccca 14880
cgctcaccgg ctccagattt atcagcaata aaccagccag ccggaagggc cgagcgcaga 14940
agtggtcctg caactttatc cgcctccatc cagtctatta attgttgccg ggaagctaga 15000
gtaagtagtt cgccagttaa tagtttgcgc aacgttgttg ccattgctac aggcatcgtg 15060
gtgtcacgct cgtcgtttgg tatggcttca ttcagctccg gttcccaacg atcaaggcga 15120
gttacatgat cccccatgtt gtgcaaaaaa gcggttagct ccttcggtcc tccgatcgtt 15180
gtcagaagta agttggccgc agtgttatca ctcatggtta tggcagcact gcataattct 15240
cttactgtca tgccatccgt aagatgcttt tctgtgactg gtgagtactc aaccaagtca 15300
ttctgagaat agtgtatgcg gcgaccgagt tgctcttgcc cggcgtcaat acgggataat 15360
accgcgccac atagcagaac tttaaaagtg ctcatcattg gaaaacgttc ttcggggcga 15420
aaactctcaa ggatcttacc gctgttgaga tccagttcga tgtaacccac tcgtgcaccc 15480
aactgatctt cagcatcttt tactttcacc agcgtttctg ggtgagcaaa aacaggaagg 15540
caaaatgccg caaaaaaggg aataagggcg acacggaaat gttgaatact catactcttc 15600
ctttttcaat attattgaag catttatcag ggttattgtc tcatgagcgg atacatattt 15660
gaatgtattt agaaaaataa acaaataggg gttccgcgca catttccccg aaaagtgcca 15720
c 15721
<210> 2
<211> 23
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<220>
<223> Tagln -Cre -F
<400> 2
gcggtctggc agtaaaaact atc 23
<210> 4
<211> 23
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<220>
<223> Tagln -Cre-R
<400> 4
gtgaaacagc attgctgtca ctt 23
<210> 4
<211> 23
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<220>
<223> Best3_LoxP_F
<400> 4
gtggctgagg caggagaatt aca 23
<210> 5
<211> 25
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<220>
<223> Best3_LoxP_R
<400> 5
aacctgtggg aaaacctcta tctcc 25
<210> 6
<211> 26
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<220>
<223> Best3_Neo_Del_F
<400> 6
cagaagtagc cgaaagccaa gatgcc 26
<210> 7
<211> 24
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<220>
<223> Best3_Neo_Del_R
<400> 7
ttacctggac gaaaaccgac agca 24

Claims (3)

1. The method for constructing the aortic dissection mouse model is characterized by comprising the following steps of: best3 with Bestrophin3 Gene loss of function SMKO Mice, rearing Best3 SMKO Mice reached 8 weeks of age or more spontaneously developed aortic dissection or aortic aneurysm; the Best3 SMKO The mice are Bestrophin3-flox homozygous and Tagln-Cre positive mice obtained by hybridization of Bestrophin3 chimeric flox heterozygous and Tagln-Cre positive mice with Bestrophin3-flox homozygous mice;
the Best3 SMKO The construction method of the mice comprises the following steps:
(1) Adopting a Cre/LoxP recombination system, selecting exon 3 and exon4 of a Bestrobin 3 gene as knockout regions, deleting the regions to cause the loss of functions of the Bestrobin 3 gene of a mouse, using a C57BL/6 mouse genome as a template to amplify an upstream homology arm, a downstream homology arm and a flox region, inserting LoxP in an intron2 of the Bestrobin 3 gene, inserting FRT-Neo expression frame-FRT-LoxP in the intron4, and connecting the regions to a framework to form a targeting vector;
(2) The targeting vector is linearized and transfected into embryo stem cells of a C57BL/6 mouse, successfully homologous recombination embryo stem cells are identified and screened through PCR, and then the embryo stem cells with positive expression are microinjected into blastula and transplanted into pseudopregnant mice;
(3) Obtaining F1 generation hybrid mice through passage, and identifying the obtained Bestrophin3-flox heterozygote mice by utilizing PCR;
(4) Selfing and PCR screening the Bestrophin3-flox heterozygote mice to obtain Bestrophin3-flox homozygous mice, then hybridizing and breeding the Bestrophin3-flox homozygous mice with vascular smooth muscle cre tool mice to obtain F1 generation hybrid mice, separating milk at 3 weeks and identifying the genotype of the mice by using a rat tail method, and hybridizing the Bestrophin3 chimeric flox heterozygotesAnd the Tagln-Cre positive mice are hybridized with the Bestrophin3-flox homozygous mice again, and the Best3 which is homozygous for the Bestrophin3-flox and positive for the Tagln-Cre is obtained through PCR identification and screening SMKO A mouse;
the Best3 SMKO The sequence of the mouse targeting vector is shown as SEQ ID NO. 1.
2. The method of constructing an aortic dissection mouse model according to claim 1, wherein in Best3 SMKO Starting the 4 th week of raising, and simultaneously inducing angiotensin II into mice for 28 days or more, wherein the induction concentration of angiotensin II is 1-2 mg.kg -1 ·d -1
3. The use of an aortic dissection mouse model constructed by the construction method of the aortic dissection mouse model according to any one of claims 1-2 in screening a drug for treating aortic dissection or aortic aneurysm.
CN202210598098.XA 2022-05-30 2022-05-30 Construction method of Bestrophin3 vascular smooth muscle specific gene knockout mice and aortic dissection mice models Active CN114875067B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210598098.XA CN114875067B (en) 2022-05-30 2022-05-30 Construction method of Bestrophin3 vascular smooth muscle specific gene knockout mice and aortic dissection mice models

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210598098.XA CN114875067B (en) 2022-05-30 2022-05-30 Construction method of Bestrophin3 vascular smooth muscle specific gene knockout mice and aortic dissection mice models

Publications (2)

Publication Number Publication Date
CN114875067A CN114875067A (en) 2022-08-09
CN114875067B true CN114875067B (en) 2023-06-30

Family

ID=82679905

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210598098.XA Active CN114875067B (en) 2022-05-30 2022-05-30 Construction method of Bestrophin3 vascular smooth muscle specific gene knockout mice and aortic dissection mice models

Country Status (1)

Country Link
CN (1) CN114875067B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109652542A (en) * 2019-01-03 2019-04-19 山东大学 Gs α gene is preparing the application in anti-abdominal aorta tumor medicine
WO2020014600A1 (en) * 2018-07-13 2020-01-16 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Green algal bestrophin bicarbonate transporters

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3374494A4 (en) * 2015-11-11 2019-05-01 Coda Biotherapeutics, Inc. Crispr compositions and methods of using the same for gene therapy
CN111518830A (en) * 2020-05-07 2020-08-11 南开大学 Establishment method of Ankle2 gene knock-out mouse model based on Cre/Loxp system
CN111909958B (en) * 2020-07-09 2023-12-29 西安医学院 Construction of vascular smooth muscle cell conditional knockout Yap1 gene mouse model

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020014600A1 (en) * 2018-07-13 2020-01-16 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Green algal bestrophin bicarbonate transporters
CN109652542A (en) * 2019-01-03 2019-04-19 山东大学 Gs α gene is preparing the application in anti-abdominal aorta tumor medicine

Also Published As

Publication number Publication date
CN114875067A (en) 2022-08-09

Similar Documents

Publication Publication Date Title
KR20190120287A (en) Genome Editing System and Method
CN109609636B (en) Detection kit for differential expression of circRNA (circulating ribonucleic acid) of lung adenocarcinoma and application of detection kit
CN115038789A (en) Therapeutic editing
CN108531510B (en) Application of transgenic zebra fish in preparation of animal model of chronic myelocytic leukemia
CN110777144B (en) sgRNA guide sequence of specific target mouse Krt14 gene and application thereof
US6187991B1 (en) Transgenic animal models for type II diabetes mellitus
KR20200086902A (en) A vector for monitoring differentiation of neural cells and method for monitoring the differentiation into neural cells using the same
CN114875067B (en) Construction method of Bestrophin3 vascular smooth muscle specific gene knockout mice and aortic dissection mice models
CN113046369B (en) Novel mRNA vaccine of coronavirus
CN109251897A (en) A kind of 3 type strain of pig circular ring virus and its preparation method and application
CN107034233B (en) Method for driving exogenous gene expression by endogenous promoter
CN110878301B (en) sgRNA guide sequence of specific target mouse G6pc gene and application thereof
US20030186266A1 (en) Highly sensitive nucleic acid hybridization method and gene analysis method by using the same
CN102250951B (en) Method for cultivating zebrafish with fluorescence conversion function in cardiovascular system by using artificial chromosome recombinant technology
CN107164405A (en) The method that tool inhibiting activity of acetylcholinesterase material is detected with transgenic zebrafish
CN110944656B (en) Novel polynucleotides encoding human FKRP proteins
CN111560392B (en) MiRNA expression vector and application thereof
CN112852869A (en) Method for constructing mouse model with limb deformity
CN110115770B (en) Novel target for preventing and treating viral hepatitis C, CRISPR-Cas9 targeting system and application thereof
CN110944656A (en) Novel polynucleotides encoding human FKRP proteins
Casquero-Fernández-de-Ana Characterization of potential therapeutic targets in Leishmania infantum
CN110862982B (en) sgRNA guide sequence of specific targeting mouse Gaa gene and application thereof
KR20120043657A (en) Method for mass production of factor vii/viia
CN110777145B (en) sgRNA guide sequence of specific targeting mouse Galt gene and application thereof
CN110885821B (en) sgRNA guide sequence of specific target mouse Idua gene and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant